Chemoinformaics analysis of 9,17-OCTADECADIENAL, (Z)-
| Molecular Weight | 264.453 | nRot | 15 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 3 |
| Exact Molecular Weight | 264.245 | nRing | 0 |
| Solubility: LogS | -5.917 | nHRing | 0 |
| Solubility: LogP | 6.72 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 52.1994 |
| nHD | 0 | BPOL | 32.9706 |
| QED | 0.201 |
| Synth | 2.465 |
| Natural Product Likeliness | 1.146 |
| NR-PPAR-gamma | 0.757 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.749 |
| MDCK | 0.0000141 |
| BBB | 0.942 |
| PPB | 0.948173 |
| VDSS | 2.426 |
| FU | 0.0171996 |
| CYP1A2-inh | 0.472 |
| CYP1A2-sub | 0.184 |
| CYP2c19-inh | 0.424 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.292 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.433 |
| CYP2d6-sub | 0.631 |
| CYP3a4-inh | 0.66 |
| CYP3a4-sub | 0.054 |
| CL | 3.809 |
| T12 | 0.165 |
| hERG | 0.102 |
| Ames | 0.072 |
| ROA | 0.011 |
| SkinSen | 0.988 |
| Carcinogencity | 0.163 |
| EI | 0.972 |
| Respiratory | 0.921 |
| NR-Aromatase | 0.144 |
| Antiviral | Yes |
| Prediction | 0.626338 |